Therafuse

TheraCell is a regenerative medicine company specializing in advanced allograft solutions for bone and soft tissue repair. The company is the developer of the proprietary TheraFuze DBF (Demineralized Bone Fiber) technology, which utilizes a unique fiber geometry to provide superior handling properties and osteoinductive potential for orthopedic and spinal surgeries. Its product portfolio includes the TheraFuze DBF Fiber Anchor, Fiber Bag, and FiberWrap, designed to enhance hardware fixation and promote bone formation in complex surgical procedures. In April 2022, TheraCell was acquired by Isto Biologics, which integrated the TheraFuze technology into its orthobiologics portfolio.